HIPAA Compliance Guide for Cardio-Oncology Specialty Programs

Cardio-oncology programs coordinate care across cancer treatment, cardiology, imaging, pharmacy, and other services. Because that coordination may involve sensitive health information, a practical HIPAA compliance guide should clarify which organization is responsible, when information can be shared, and how it must be protected.

When HIPAA applies to a cardio-oncology program

HIPAA usually applies based on the legal status and activities of the organization—not because it offers a particular specialty. A health care provider is generally a HIPAA covered entity if it electronically conducts a transaction for which HHS has adopted a standard, such as certain electronic claims or eligibility transactions. Health plans and health care clearinghouses are also covered entities. See HHS guidance on who must comply with HIPAA privacy standards.

For the covered entity determination, identify which organization employs or contracts with the cardio-oncology workforce, operates the clinical record system, submits standard electronic transactions, and makes decisions about patient information. A specialty program within a hospital or health system will commonly follow that organization’s HIPAA policies; a separately operated clinic may need to assess its own status. The covered entity remains responsible for applicable HIPAA duties even when it uses vendors to perform services.

HIPAA generally protects individually identifiable health information held or transmitted by a covered entity or its business associate. In a cardio-oncology setting, that may include clinic notes, cardiac imaging and test results, cancer treatment information, medication lists, referrals, and communications that identify a patient. Confirm which entity’s policies govern the program and how they apply to shared records and outside clinicians.

How privacy rules support patient rights and permitted disclosures

HIPAA’s Privacy Rule gives patients rights over their protected health information (PHI), including rights to access records, request corrections, and ask for certain restrictions. Patients can also make a confidential communications request, such as asking the program to contact them at a particular phone number or address. Covered providers generally must accommodate reasonable requests. HHS’s model Notice of Privacy Practices describes these and other rights.

The program’s Notice of Privacy Practices explains how the covered entity may use and disclose PHI and how patients can exercise their rights. A notice does not, by itself, authorize a use or disclosure that HIPAA otherwise requires the patient to authorize. When an authorization is required, the program must obtain a valid authorization rather than relying on notice language.

HIPAA permits covered entities to use or disclose PHI for treatment, payment, and health care operations in many circumstances without the patient’s authorization. For example, care teams may use relevant information to coordinate clinical services, while billing staff may use information for payment activities under applicable policies. Treatment permission under HIPAA is separate from informed consent to medical care, which is addressed by other laws and policies.

Patients may ask the program to restrict certain uses or disclosures, but a covered entity does not have to agree to every request. One important exception is when a patient pays in full out of pocket for a health care item or service and requests that the information not be disclosed to their health plan for payment or health care operations; the covered entity generally must honor that request unless disclosure is required by law.

How to share protected health information for care coordination

Cardio-oncology care may involve communication between oncologists, cardiologists, primary care clinicians, imaging teams, pharmacists, and other providers. HIPAA generally allows a covered provider to disclose PHI to another health care provider for treatment—including consultation and care coordination—without obtaining the patient’s authorization. HHS confirms that provider consultation about a patient is a treatment activity in its guidance on treatment, payment, and health care operations disclosures.

Use approved channels and follow organizational procedures when sharing information. Depending on the clinical purpose, useful information may include a treatment plan, cardiac test results, relevant medication information, or follow-up recommendations. Confirm the recipient’s identity and ensure the information reaches the provider or care team involved in treatment.

HIPAA’s treatment permission does not mean every person involved in a patient’s life may receive clinical details. When communicating with family members, caregivers, or others involved in care, follow the Privacy Rule and program policy regarding the patient’s agreement, opportunity to object, or professional judgment about what is appropriate. Check whether a separate law or a specific category of information imposes additional requirements.

Document and route disclosures according to the covered entity’s policies, especially when a disclosure is not for treatment or involves an unusual recipient or purpose. HIPAA may require written authorization for uses or disclosures that are not otherwise permitted or required by the Privacy Rule.

Applying the minimum necessary standard and its treatment exception

When the minimum necessary standard applies, a covered entity must make reasonable efforts to limit the use, disclosure, or request of PHI to what is needed for the intended purpose. The entity should have policies that address routine activities and criteria for reviewing non-routine requests and disclosures.

The standard has an important treatment exception: it does not apply to disclosures to, or requests by, a health care provider for treatment purposes. Accordingly, a cardio-oncology clinician may request or share the information reasonably needed for a patient’s treatment without applying the minimum necessary standard to that provider-to-provider treatment disclosure. HHS explains this exception in its minimum necessary guidance.

The exception does not eliminate other privacy and security duties. For example, internal workforce access should still follow role-based policies, and disclosures for payment or health care operations remain subject to the minimum necessary standard when applicable. A program may also choose practical information-sharing limits for treatment workflows, provided they do not obstruct appropriate care.

Security safeguards and risk analysis for electronic protected health information

The HIPAA Security Rule requires covered entities and business associates to protect the confidentiality, integrity, and availability of electronic protected health information (ePHI) using appropriate administrative, physical, and technical safeguards. HHS describes these requirements in its overview of the Security Rule.

An electronic protected health information risk analysis is a required starting point. The organization must assess potential risks and vulnerabilities to the ePHI it creates, receives, maintains, or transmits, then implement measures to reduce risks to a reasonable and appropriate level. The analysis should account for the program’s information flows and systems, including clinical records, imaging and test results, referrals, messaging, mobile devices, and relevant vendor services. See HHS guidance on Security Rule risk analysis.

Use the findings to select and maintain safeguards suited to the organization’s environment. Examples of practical measures include access controls based on job duties, workforce procedures for handling records, secure workstations and devices, physical access controls, audit-log review, and protections for electronic transmissions. These are implementation considerations; the specific measures should be determined through the covered entity’s risk analysis and applicable Security Rule requirements.

Revisit the risk analysis when technology, workflows, vendors, or threats change, and document decisions and remediation steps. The Security Rule requires ongoing risk management, not simply a one-time assessment or purchase of a security product.

Business associate agreements for cardio-oncology services

A business associate is generally a person or organization that performs certain functions or services for a covered entity involving PHI on the entity’s behalf. Depending on its role and access, a vendor supporting hosting, billing, data processing, or another service may be a business associate. A provider receiving information from another provider to treat a patient is not, merely because of that treatment disclosure, acting as the disclosing provider’s business associate.

Before allowing a business associate to create, receive, maintain, or transmit PHI on the covered entity’s behalf, the parties generally need a written business associate agreement (BAA) or other arrangement that meets HIPAA requirements. A BAA should define permitted and required uses and disclosures, require appropriate safeguards, and require the business associate to report impermissible uses or disclosures and breaches of unsecured PHI to the covered entity. HHS summarizes required terms in its guidance on business associate contract provisions.

The agreement should also address relevant individual rights requests, HHS access to records for compliance purposes, subcontractors that handle PHI, and return or destruction of PHI when the agreement ends where feasible. Confirm the arrangement before sharing information with a vendor, and review the organization’s procedures for responding to a business associate’s noncompliance.

Workforce training and breach notification responsibilities

Covered entities must train workforce members on relevant PHI policies and procedures as necessary and appropriate for their roles. Training must be provided to new workforce members within a reasonable period and to affected workforce members after a material policy change; the covered entity must document that training. This is not a universal federal requirement for an annual training certificate renewal. The program should provide employer-specific guidance on matters such as access, secure communications, records handling, incident reporting, and escalation. See the HHS audit protocol’s training requirements.

Workforce members should promptly report suspected loss, unauthorized access, misdirected communications, or other possible privacy or security incidents through the organization’s established process. A covered entity must assess whether an impermissible use or disclosure is a breach of unsecured protected health information; such an incident is generally presumed to be a breach unless an exception applies or a documented risk assessment shows a low probability that the PHI was compromised.

After a reportable breach of unsecured PHI, the covered entity generally must notify affected individuals without unreasonable delay and no later than 60 calendar days after discovery. Notice to HHS and, in some cases, the media also may be required, with reporting details dependent on the number of people affected. A business associate must notify the covered entity of a breach; the agreement may set a shorter operational reporting deadline. HHS summarizes these duties in its Breach Notification Rule guidance.

In summary, a cardio-oncology program should identify the covered entity responsible for its operations, use HIPAA’s treatment permissions appropriately, respect patient rights, assess ePHI risks, manage business associate relationships, train its workforce, and follow established incident and breach procedures.

FAQs

Does HIPAA apply to every cardio-oncology specialty program?

No. HIPAA applies according to the organization’s role and activities, not its specialty name. A provider that electronically conducts certain standardized health care transactions is generally a covered entity, as are health plans and health care clearinghouses. A program operating within a covered hospital or health system will generally follow that entity’s HIPAA policies.

Can cardio-oncology providers share patient information for treatment without authorization?

Generally, yes. HIPAA permits covered providers to use or disclose PHI for treatment, including provider consultation and care coordination, without the patient’s authorization. Providers should still follow organizational procedures and check for other laws or special circumstances that may impose additional requirements.

Does the minimum necessary standard apply to provider-to-provider treatment disclosures?

No. The Privacy Rule expressly exempts disclosures to, and requests by, a health care provider for treatment purposes from the minimum necessary standard. The standard still applies to many other uses, disclosures, and requests, including those for payment or health care operations when applicable.

What must a business associate agreement cover?

A BAA must describe permitted and required uses and disclosures of PHI, restrict other uses and disclosures, require appropriate safeguards and breach reporting, and address applicable individual rights requests. It must also include required provisions concerning subcontractors, HHS access to relevant records, and return or destruction of PHI at termination where feasible.